Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been ...

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...

The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...

FDA Commissioner Marty Makary, whose agency convened a panel of experts earlier in the day to discuss the topic, told ...

US health authorities on Thursday began a reassessment of the risks surrounding Hormone Replacement Therapy (HRT), a ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...